Shopping Cart
- Remove All
- Your shopping cart is currently empty
Semaglutide TFA is a glucagon-like peptide-1 congener that induces weight loss, lowers blood glucose levels, and reduces cardiovascular risk in diabetic patients.Semaglutide TFA induces mild-to-moderate and transient gastrointestinal disturbances, and may be used in the study of type 2 diabetes and obesity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $232 | In Stock | |
5 mg | $803 | Backorder |
Description | Semaglutide TFA is a glucagon-like peptide-1 congener that induces weight loss, lowers blood glucose levels, and reduces cardiovascular risk in diabetic patients.Semaglutide TFA induces mild-to-moderate and transient gastrointestinal disturbances, and may be used in the study of type 2 diabetes and obesity. |
Targets&IC50 | GLP1 receptor:0.38 nM (Kd) |
In vitro | Semaglutide TFA is a modified GLP-1 analog with two substitutions (Aib and Arg) at amino acids 8 and 34 and a chemical modification of the lysine at position 26 compared to human GLP-1. It has an affinity for the GLP-1 receptor of 0.38 nM. [1] The amino acid sequence of Semaglutide TFA shares 94% homology with human GLP-1. [3] |
In vivo | The plasma half-life of Semaglutide TFA was 46 hours after intravenous injection and the mean retention time (MRT) was 63.6 hours after subcutaneous injection in a small pig study.[1] Semaglutide TFA significantly ameliorated dyskinesia induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In addition, it protects dopaminergic neurons in the brain by restoring tyrosine hydroxylase (TH) levels, attenuating inflammatory responses, reducing lipid peroxidation, inhibiting apoptosis and promoting the expression of autophagy-related proteins. Semaglutide TFA shows better results in most aspects compared to liraglutide. [2] Semaglutide TFA lowers blood glucose by promoting insulin secretion and is also effective in reducing body weight. [3] |
Alias | Semaglutide TFA (910463-68-2 free base) |
Molecular Weight | 4225.6482 |
Formula | C189H290F3N45O61 |
Smiles | CC[C@@H]([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(O)=O)=O)CCCNC(N)=N)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)CC(C)C)=O)Cc(cn1)c2c1cccc2)=O)C)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](NC([C@H]([C@H](O)C)NC(CNC([C@@H](NC(C(C)(NC([C@H](Cc3ncnc3)N)=O)C)=O)CCC(O)=O)=O)=O)=O)Cc4ccccc4)=O)=O)CO)=O)CC(O)=O)=O)=O)CO)=O)CO)=O)Cc5ccc(O)cc5)=O)CC(C)C)=O)CCC(O)=O)=O)=O)CCC(N)=O)=O)C)=O)C)=O)CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](C(O)=O)NC(CCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)=O)CCC(O)=O)=O)Cc6ccccc6)=O)C.OC(C(F)(F)F)=O |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | H2O: 80 mg/mL (18.93 mM), Sonication is recommended. DMSO: 80 mg/mL (18.93 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
H2O/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.